Officials could communicate the committee's advice from the meeting, as has happened in the past, and the minister could act accordingly. That could involve accepting the advice, making a decision to ensure patients maintain reimbursed access, as he has prioritised, or both. Probably best to resolve it quickly for patients.
It might make sense to follow the process, mostly, but no need to keep patients waiting
July 9, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Territory partnership backs digital health push for diabetes, kidney and heart care
July 9, 2026 - - Latest News -
It might make sense to follow the process, mostly, but no need to keep patients waiting
July 9, 2026 - - Latest News -
Illumina taps medtech leader to head Australia and New Zealand operations
July 8, 2026 - - Latest News -
PYC Therapeutics names Thomas Ulmer as new chief financial officer
July 8, 2026 - - Australian Biotech -
In a perfect world, the minister would not be in this position, and he might question the timeline
July 8, 2026 - - Latest News -
Aegros completes Australia’s second large scale plasma fractionation plant
July 8, 2026 - - Latest News -
'But I've said it's really important that these two drugs stay on the PBS'
July 7, 2026 - - Latest News

